| Literature DB >> 22304420 |
Takahisa Shiraishi1, Toshiyuki Yamamoto.
Abstract
Dyshidrotic eczema is one of the rare cutaneous adverse effects of intravenous immunoglobulin therapy, usually seen in adults. We herein report the first pediatric case of severe dyshidrotic eczema occurring after intravenous immunoglobulin therapy for Kawasaki syndrome.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22304420 DOI： 10.1111/j.1525-1470.2011.01717.x
Source DB: PubMed Journal: Pediatr Dermatol ISSN： 0736-8046 Impact factor: 1.588